跳至主要内容
临床试验/EUCTR2007-004894-25-SE
EUCTR2007-004894-25-SE进行中(未招募)不适用

Effect of rosuvastatin on cardiovascular events and mortality after pneumonia

Karolinska University Hospital Huddinge0 个研究点开始时间: 2009年4月22日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - age 55-85 years old
  • - CAP diagnose
  • - Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years)
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Previous participation in the study
  • - pervious participation in any other clinical trial, within 6 months period
  • - ongoing drug treatment with a statin or any other lipidlowering therapy
  • - co-morbid condition with a life expectancy less than one year
  • - serum ASAT or Serum ALAT>times UNL
  • - serum creatinin kinase (s-CK) > 5 times UNL
  • - serum kreatinin (S-Krea) > 200µkat/L
  • -poorly controlledhypothyroid function
  • - inhereditied myopathia
  • - alcoholdependecy
  • - drug treatment with erytromycin, proteas inhibitors, gemfibrozil, ciklosporin, niacin, fibrates (except fenofibrate) and ezetemib
  • - any other condition after judgement of the investigator would make the patient unsuiteable for enrollment, or could interfere with the study protocol
  • -preganacy or planned pregnancy or breastfeeding

研究者

发起方
Karolinska University Hospital Huddinge

相似试验